BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33434067)

  • 1. Chronic Lymphocytic Leukemia: Prognostic Factors at Presentation in a Resource-Limited Center.
    Korubo KI; Okite UP; Ezeugwu SI
    JCO Glob Oncol; 2021 Jan; 7():56-62. PubMed ID: 33434067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of four prognostic scoring system in patients with early asymptomatic chronic lymphocytic leukemia patients].
    Sha YQ; Shen H; Wu W; Xia Y; Miao Y; Cao L; Wang L; Fan L; Xu W; Li JY; Zhu HY
    Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):834-839. PubMed ID: 34788923
    [No Abstract]   [Full Text] [Related]  

  • 3. The management of chronic lymphocytic leukemia at a single centre over a 24-year period: prognostic factors for survival.
    Karmiris T; Rohatiner AZ; Love S; Carter M; Ganjoo RK; Amess J; Norton AJ; Lister TA
    Hematol Oncol; 1994; 12(1):29-39. PubMed ID: 7515019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Watch and Wait in Lebanese Chronic Lymphocytic Leukemia Patients: How Relevant is it?
    Lutfallah AA; Kourie HR; Eid R; Farhat F; Ghosn M; Kattan J
    Asian Pac J Cancer Prev; 2016; 17(1):215-7. PubMed ID: 26838212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Binet Staging versus Tumour Bulk on Treatment Outcome in Chronic Lymphocytic Leukaemia.
    Madu AJ; Okoye HC; Muoghalu EA; Ugwu AO; Duru AN; Nonyelu CE; Anigbogu IO; Ezekekwu CA
    Niger Postgrad Med J; 2024 Jan; 31(1):76-80. PubMed ID: 38321800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presenting features and treatment outcomes of chronic lymphocytic leukaemia in a resource poor Southern Nigeria.
    Madu AJ; Korubo K; Okoye A; Ajuba I; Duru AN; Ugwu AO; Nnachi O; Okoye HC
    Malawi Med J; 2019 Jun; 31(2):144-149. PubMed ID: 31452848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of chronic lymphocytic leukemia and small lymphocytic lymphoma by absolute lymphocyte counts in 2,126 patients: 20 years of experience at the University of Texas M.D. Anderson Cancer Center.
    Tsimberidou AM; Wen S; O'Brien S; McLaughlin P; Wierda WG; Ferrajoli A; Faderl S; Manning J; Lerner S; Mai CV; Rodriguez AM; Hess M; Do KA; Freireich EJ; Kantarjian HM; Medeiros LJ; Keating MJ
    J Clin Oncol; 2007 Oct; 25(29):4648-56. PubMed ID: 17925562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment.
    Hallek M
    Am J Hematol; 2019 Nov; 94(11):1266-1287. PubMed ID: 31364186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External validation of International Prognostic Score for asymptomatic early stage chronic lymphocytic leukaemia and proposal of an alternative score.
    Smolej L; Turcsányi P; Kubová Z; Zuchnická J; Mihályová J; Šimkovič M; Vodárek P; Krčméryová M; Móciková H; Brejcha M; Špaček M;
    Br J Haematol; 2021 Apr; 193(1):133-137. PubMed ID: 33280081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia.
    Bulian P; Tarnani M; Rossi D; Forconi F; Del Poeta G; Bertoni F; Zucca E; Montillo M; Pozzato G; Deaglio S; D'Arena G; Efremov D; Marasca R; Lauria F; Gattei V; Gaidano G; Laurenti L
    Hematol Oncol; 2011 Jun; 29(2):91-9. PubMed ID: 20669154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentation, progression, and outcome of patients with clonal B-cell counts of less than 5 × 10(9)/l, 5 to 10 × 10(9)/l, and more than 10 × 10(9)/l and chronic lymphocytic leukemia immunophenotype.
    Foster AE; Nguyen TT; Al-Hammadi N; Frater JL; Hassan A; Kreisel F
    Am J Clin Pathol; 2015 Jan; 143(1):70-7. PubMed ID: 25511144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic significance of CLL-IPI for Chinese patients with chronic lymphocytic leukemia].
    Zhu HY; Wang L; Qiao J; Zou YX; Xia Y; Wu W; Cao L; Liang JH; Fan L; Xu W; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2018 May; 39(5):392-397. PubMed ID: 29779348
    [No Abstract]   [Full Text] [Related]  

  • 14. Epidemiology of chronic lymphocytic leukemia in Chilean and Amerindian population in Chile.
    Cabrera ME; Marinov N; Roa M; Castillo JJ; Matutes E
    Leuk Lymphoma; 2022 May; 63(5):1137-1143. PubMed ID: 34886754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistently low lymphocyte counts after FCR therapy for chronic lymphocytic leukemia are associated with longer overall survival.
    Joffe E; Ariela Arad N; Bairey O; Fineman R; Ruchlemer R; Rahimi-Levene N; Shvidel L; Greenbaum U; Aviv A; Tadmor T; Braester A; Goldschmidt N; Polliack A; Herishanu Y
    Hematol Oncol; 2018 Feb; 36(1):128-135. PubMed ID: 28639416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: a universally available prognostic test.
    Nowakowski GS; Hoyer JD; Shanafelt TD; Geyer SM; LaPlant BR; Call TG; Jelinek DF; Zent CS; Kay NE
    Mayo Clin Proc; 2007 Apr; 82(4):449-53. PubMed ID: 17418074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic value of absolute monocyte count in chronic lymphocytic leukaemia].
    Szerafin L; Jakó J; Riskó F
    Orv Hetil; 2015 Apr; 156(15):592-7. PubMed ID: 25845318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic factors for chronic lymphocytic leukemia with typical and atypical immunophenotype].
    Cao X; Xu W; Wu YJ; Qiao C; Liu Q; Fan L; Miao KR; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jul; 30(7):450-3. PubMed ID: 19954596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface CD14 positivity in B-cell chronic lymphocytic leukaemia is related to clinical outcome.
    Callea V; Morabito F; Oliva BM; Stelitano C; Levato D; Dattilo A; Gangemi F; Iorfida A; Iacopino P; Nobile F; Molica S; Brugiatelli M
    Br J Haematol; 1999 Nov; 107(2):347-52. PubMed ID: 10583223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the CLL-IPI in relapsed and refractory chronic lymphocytic leukemia in idelalisib phase-3 trials.
    Soumerai JD; Ni A; Xing G; Huang J; Furman RR; Jones J; Sharman JP; Hallek M; Adewoye AH; Dubowy R; Dreiling L; Zelenetz AD
    Leuk Lymphoma; 2019 Jun; 60(6):1438-1446. PubMed ID: 30407886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.